WO2024003942 - AN IMPROVED PROCESS FOR THE PREPARATION OF SELUMETINIB SULFATE

National phase entry is expected:
Publication Number WO/2024/003942
Publication Date 04.01.2024
International Application No. PCT/IN2023/050628
International Filing Date 28.06.2023
Title **
[English] AN IMPROVED PROCESS FOR THE PREPARATION OF SELUMETINIB SULFATE
[French] PROCÉDÉ AMÉLIORÉ DE PRÉPARATION DE SULFATE DE SÉLUMÉTINIB
Applicants **
NATCO PHARMA LIMITED
Inventors
KRISHNAMMAGARI, Suresh Kumar
CHINTALAPATI, Srinivasa Chary
THOOTA, Sandeep Kumar
BAREDDY, Vishnu Vardhan Reddy
KADARI, Ushaiah
PEDDI, Rajasekhara Reddy
ABAYEE KALIYAPERUMAL, Srinivasan
MUDDASANI, Pulla Reddy
NANNAPANENI, Venkaiah Chowdary
Priority Data
202241037974   01.07.2022   IN
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting1956
EPO Filing, Examination, Granting11576
Japan Filing, Examination, Granting2001
South Korea Filing, Examination, Granting1805
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 22,078

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] The present invention relates to an improved process for the preparation of 5 Selumetinib sulfate of Formula-(I).[French] La présente invention concerne un procédé amélioré pour la préparation de sulfate de sélumétinib de formule (I).